Emyria Ltd’s (ASX:EMD) advanced remote monitoring digital health platform and service - Openly - will play a central role in a recently awarded grant from Western Australia’s Future Health Research and Innovation Fund.
The grant totals $880,000, of which Emyria expects to receive between $320,000 and $400,000 over the course of two years.
The successful grant is titled “An advanced digital monitoring and engagement platform for at-risk and confirmed COVID-19 individuals” and is intended to boost Western Australia’s digital health infrastructure and capacity to manage future health challenges like COVID-19.
The grant's aims include evaluating the utility of advanced digital health monitoring in vulnerable patient populations, to improve engagement amongst aged and ethnic populations and to improve mental health evaluation and monitoring for those under remote care.
Openly to support patients during trials
Managing director Dr Michael Winlo said: “It’s very pleasing to see our unique contactless remote monitoring platform - Openly - recognised through this competitive grant process.
“Emyria’s unique digital health technology and clinical team will be playing a major role in improving how we monitor the clinical and mental wellbeing of vulnerable populations in WA.
“Openly - the core technology of this grant - will also support and monitor patients during our upcoming clinical trials.
“These pivotal studies will support the registration of our leading drug candidate EMD-003 - targeting unmet needs in psychological distress and the symptoms of anxiety, depression and stress.”
Emyria will take a leadership role in the grant and will lead a multidisciplinary collaboration involving the state’s major health services and universities.
The grant will also extend Emyria’s collaboration with Mt Sinai, New York.